Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Nanoparticle Formulation : SOP for Preparation of Carbon-Based Nanomaterials

Posted on By

SOP for Preparation of Carbon-Based Nanomaterials

Standard Operating Procedure for Preparation of Carbon-Based Nanomaterials

1) Purpose

This SOP outlines the procedure for the preparation of carbon-based nanomaterials, such as carbon nanotubes, graphene, and fullerenes, which are used in various biomedical and industrial applications.

2) Scope

This SOP applies to laboratory personnel involved in the synthesis and characterization of carbon-based nanomaterials for different research and industrial purposes.

3) Responsibilities

  • Operators: Responsible for preparing carbon-based nanomaterials following this SOP.
  • QA: Ensures that the prepared nanomaterials meet the required specifications for purity and particle size.

4) Procedure

4.1 Synthesis of Carbon Nanotubes (CNTs)

4.1.1 Chemical Vapor Deposition (CVD)

  • 4.1.1.1 Load the substrate with a metal catalyst (e.g., nickel, cobalt).
  • 4.1.1.2 Introduce a carbon-containing gas (e.g., methane) into the CVD reactor at high temperatures (600–1200°C) to grow CNTs on the substrate.
See also  Nanoparticle Formulation : SOP for Preparation of Magnetic Nanoparticles for Biomedical Applications

4.2 Preparation of Graphene

4.2.1 Exfoliation Method

  • 4.2.1.1 Prepare graphene by exfoliating graphite in a suitable solvent (e.g., N-methyl-2-pyrrolidone) under sonication.

4.3 Purification and Characterization

4.3.1 Purification

  • 4.3.1.1 Purify the nanomaterials by washing them with solvents to remove impurities.

4.3.2 Particle Size Measurement

  • 4.3.2.1 Measure the particle size and surface area of the carbon-based nanomaterials using scanning electron microscopy (SEM) or transmission electron microscopy (TEM).

4.4 Storage

4.4.1 Storage Conditions

  • 4.4.1.1 Store the carbon-based nanomaterials in sealed containers at room temperature.

5) Abbreviations, if any

  • CVD: Chemical Vapor Deposition
  • CNT:
Carbon Nanotube
  • SEM: Scanning Electron Microscopy
  • TEM: Transmission Electron Microscopy
  • 6) Documents, if any

    • Carbon-Based Nanomaterial Synthesis Logbook

    7) References, if any

    • Protocols for carbon-based nanomaterial synthesis and characterization

    8) SOP Version

    Version 1.0

    Annexure

    Carbon-Based Nanomaterial Synthesis Logbook Template

    Date Batch Number Material Type Synthesis Method Particle Size Operator Initials QA Initials
    DD/MM/YYYY Batch Number Graphene/CNT/Fullerene Synthesis Method (e.g., CVD) Size in nm Operator Name QA Name
               
    See also  Nanoparticle Formulation : SOP for Preparation of Metal Nanoparticles
    Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

    Post navigation

    Previous Post: SOP for Formulating pH-Sensitive Liposomes
    Next Post: SOP for Incorporation of Taste-Masking Agents in Lyophilized Products

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version